Buy back and cancel some restricted A shares granted under the A-share plan for 2025 by Asymchem Laboratories (06821).

20:57 13/03/2026

Kailaiying (06821) announced that on March 13, 2026, the board of directors of the company reviewed and approved the "Proposal on Repurchasing and Cancelling a Portion of Restricted Shares Under the 2025 A-share Plan", under which a total of 61,000 shares will be repurchased and cancelled by (i) four incentive recipients who have resigned and were initially granted in accordance with the 2025 A-share plan, and (ii) one incentive recipient who has resigned and holds restricted A-share shares granted but not yet vested under the 2025 A-share plan (repurchase and cancellation matters).

Asymchem Laboratories (06821) announced on March 13, 2026, that the Board of Directors has reviewed and approved the "Proposal on Repurchasing and Cancelling a Portion of Restricted Shares under the 2025 A-share Plan". This involves repurchasing and cancelling a total of 61,000 shares held by (i) four resigned incentive recipients granted under the 2025 A-share Plan and (ii) one resigned incentive recipient holding unvested restricted A-share shares reserved under the 2025 A-share Plan (repurchase and cancellation).

At the end of February, the net asset value per share of PROSP INV HOLD (00310) was approximately 0.029 Hong Kong dollars.

On March 13, IFBH (06603) spent 573,100 Hong Kong dollars to repurchase 50,000 shares.

GHPC (01847) issues profit warning, expecting net loss to increase to approximately 169 million yuan in 2025.

At the end of February, the net asset value per share of PROSP INV HOLD (00310) was approximately 0.029 Hong Kong dollars.

On March 13, IFBH (06603) spent 573,100 Hong Kong dollars to repurchase 50,000 shares.

GHPC (01847) issues profit warning, expecting net loss to increase to approximately 169 million yuan in 2025.